Study Stopped
Fellow left UF study never started
Virtual Planning of ALT Flap
Virtual Planning Of Anterolateral Thigh Free Flap for Reconstruction Of Hemiglossectomy
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
This study evaluates the advantage of using preoperative virtual planning to design the volume and shape of antero-lateral thigh free flap tissue transfer to reconstruct tongue defects resulted from carcinoma resection and see how this would affect tongue form and speech function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2023
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2022
CompletedFirst Posted
Study publicly available on registry
June 21, 2022
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedJune 24, 2024
June 1, 2024
2 years
June 9, 2022
June 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prospectively evaluate a new method of virtually planned ALTF and changes in flap volume for the reconstruction of tongue defects following hemi-glossectomy
Investigators will preoperatively use CT measurements and virtual planning 3D software to calculate the required ALT flap volume /cm3 by measuring flap dimensions (height, width and length) /cm3 and compare it with the postoperative real outcomes by re-measuring the real flap dimensions ( height, width and length) /cm3 .
Changes in flap volume/cm3 will be measured after one and six months after surgery where the preoperative virtually planned volume/cm3 is being the base line.
Secondary Outcomes (1)
Assessment of Intelligibility of Dysarthric Speech (AIDS) test will be used to assess tongue speech functions following tongue reconstruction and compare speech changes.
Changes of speech will be compared After one and six months after surgery where the preoperative speech will be the base line.
Study Arms (2)
Study Group: ALTF with preoperative virtual planning
EXPERIMENTALSubjects will receive ALTF( Anterolateral thigh flap) with preoperative virtual planning
Control Group: ALTF with conventional method
ACTIVE COMPARATORSubjects will receive ALTF (Anterolateral thigh flap) with conventional method
Interventions
In this study group, using preoperative CTs (head \& neck and thigh ) to virtually plan a guide that can be used during the surgery, this guide will determine the design and dimensions of the Alt flap to be harvested and restore the defect left on the tongue due SCC resection and hemi glossectomy.
ALTF (Anterolateral thigh flap) will be harvested with conventional method which depends on surgeon's own experience in determining the flap design and dimensions needed to reconstruct and restore the defect left on the tongue due SCC resection and hemi glossectomy.
Eligibility Criteria
You may qualify if:
- Patients with primary tongue squamous cell carcinoma (SCC) requiring hemi-glossectomy.
- No alveolar ridge involvement by the tumor process.
- Planned to undergo tongue reconstruction using ALTF.
- Patients with a depth of invasion more than 10mm but not crossing midline according to the classification of Ansarin et. al., we perform type IIIA glossectomy.
You may not qualify if:
- Medically unfit patients; those who are not good candidates for long microvascular surgical reconstructive procedures e.g.: advanced Cardiopulmonary diseases.
- Recurrent tongue carcinoma.
- Patients with lesions invading the alveolar ridge.
- Missing or non-compliance for imaging investigations.
- Patients underwent preoperative adjuvant therapies.
- No children will be involved in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Rui Fernandes, MD, DMD
University of Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2022
First Posted
June 21, 2022
Study Start
September 1, 2023
Primary Completion
September 1, 2025
Study Completion
September 1, 2025
Last Updated
June 24, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share